Using our AWS cloud-based pipeline and mass spectrometry analysis to identify candidate peptides. AWS provides enormous scalability to ensure we can obtain results quickly even in high volume workloads

Using our AI platform which is trained per-patient to select the most immunogenic peptide targets for each patient. Our unique approach gives BreakVax vaccines an edge by offering a greater degree of personalization

Peptides manufactured per-patient means each patient gets exactly the right peptides at exactly the right doses. This optimization means more robust immune responses and better patient outcomes